Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL) stock price, news, charts, stock research, profile.
Open | $27.07 |
High | $27.07 |
52 Wk High | 27.50 |
AUM | 11.91M |
Dividend | - |
Ex-Div Date | - |
Volume | 515 |
Market Cap | $59.35B |
Mgmt Fee | 0.99% |
P/E Ratio | 29.41 |
Prev. Close | $27.16 |
Low | $27.01 |
52 Wk Low | 23.67 |
Shares Out | - |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | - |
Beta | - |
Avg. Expense Ratio | 0.75% |
P/B Ratio | 4.87 |
You can purchase shares of Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) through any online brokerage.
There are no as such competitors for Tema Neuroscience and Mental Health ETF.
There is no analysis for Tema Neuroscience and Mental Health ETF.
There is no analysis for Tema Neuroscience and Mental Health ETF to provide a consensus price target.
The stock price for Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL) is $27.26 last updated July 17, 2024 at 9:30 AM EDT.
There are no upcoming dividends for Tema Neuroscience and Mental Health ETF.
Tema Neuroscience and Mental Health ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Tema Neuroscience and Mental Health ETF.
Sector | Healthcare |
Category | - |
Investment Style | Mid Cap Blend |
Fund Inception | Jan 22, 2024 |
Managers | David Song Yuri Khodjamirian |
Definition | - |
Symbol | Name | Share % |
---|---|---|
VRTX | Vertex Pharmaceuticals... | 5.43% |
LLY | Eli Lilly & Co. | 5.26% |
REGN | Regeneron Pharmaceutic... | 4.85% |
ALNY | Alnylam Pharmaceutical... | 4.69% |
BIIB | Biogen Inc. | 4.51% |
NBIX | Neurocrine Biosciences... | 4.40% |
AS | Argenx Se Spon Adr Eac... | 4.35% |
DNLI | Denali Therapeutics In... | 4.13% |
SYK | Stryker Corp | 3.67% |
IL | Teva Pharmaceutical In... | 3.59% |